Search
Leap Therapeutics Inc
LPTXAdd to Watchlist
2.050USD
0.0000.00%
Close 05/15, 16:00（ET）Quotes delayed by 15 min
115.51MMarket Cap
LossP/E TTM
More Details of Leap Therapeutics Inc Company
Leap Therapeutics, Inc. is a biopharmaceutical company. The Company is engaged in developing novel biomarker-targeted antibody therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways. The Company’s lead clinical stage drug candidate is sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1 (DKK1). DKK1 is also a modulator of CKAP4/PI3K/AKT signaling. The Company is developing DKN-01 in a clinical trial in patients with colorectal cancer and has also conducted clinical trials in patients with gastric/gastroesophageal junction cancer and endometrial cancer patients. The Company also has a preclinical program to develop a proprietary monoclonal antibody known as FL-501. FL-501 is a monoclonal antibody in preclinical development that targets growth and differentiation factor 15 (GDF15), which is a cytokine that is produced at elevated levels in response to various stresses.
Leap Therapeutics Inc Info
Ticker SymbolLPTX
Company nameCypherpunk Technologies Inc
IPO dateJan 24, 2017
CEOOnsi (Douglas E)
Number of employees52
Security typeOrdinary Share
Fiscal year-endJan 24
Address47 Thorndike Street
CityCAMBRIDGE
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code02142
Phone16172524343
Websitehttps://www.leaptx.com/
Ticker SymbolLPTX
IPO dateJan 24, 2017
CEOOnsi (Douglas E)
Company Executives of Leap Therapeutics Inc
Name
Name/Position
Position
Shareholding
Change
Dr. James H. Cavanaugh, Ph.D.
Dr. James H. Cavanaugh, Ph.D.
Independent Director
Independent Director
168.96K
+99.87%
Dr. Joseph Loscalzo, M.D., Ph.D.
Dr. Joseph Loscalzo, M.D., Ph.D.
Independent Director
Independent Director
168.75K
--
Mr. Nissim Mashiach
Mr. Nissim Mashiach
Independent Director
Independent Director
168.75K
--
Mr. Christian M. Richard
Mr. Christian M. Richard
Independent Director
Independent Director
168.75K
--
Mr. Douglas E. (Doug) Onsi
Mr. Douglas E. (Doug) Onsi
President, Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary, Director
President, Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary, Director
141.58K
+0.50%
Dr. Christopher K. Mirabelli, Ph.D.
Dr. Christopher K. Mirabelli, Ph.D.
Director
Director
132.51K
+82.07%
Ms. Christine Granfield
Ms. Christine Granfield
Vice President, Head - Regulatory Affairs and Quality
Vice President, Head - Regulatory Affairs and Quality
15.90K
--
Dr. Jason Baum, Ph.D.
Dr. Jason Baum, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
15.90K
--
Dr. Thomas Dietz, Ph.D.
Dr. Thomas Dietz, Ph.D.
Lead Independent Director
Lead Independent Director
--
--
Dr. William W. Li, M.D.
Dr. William W. Li, M.D.
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. James H. Cavanaugh, Ph.D.
Dr. James H. Cavanaugh, Ph.D.
Independent Director
Independent Director
168.96K
+99.87%
Dr. Joseph Loscalzo, M.D., Ph.D.
Dr. Joseph Loscalzo, M.D., Ph.D.
Independent Director
Independent Director
168.75K
--
Mr. Nissim Mashiach
Mr. Nissim Mashiach
Independent Director
Independent Director
168.75K
--
Mr. Christian M. Richard
Mr. Christian M. Richard
Independent Director
Independent Director
168.75K
--
Mr. Douglas E. (Doug) Onsi
Mr. Douglas E. (Doug) Onsi
President, Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary, Director
President, Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary, Director
141.58K
+0.50%
Dr. Christopher K. Mirabelli, Ph.D.
Dr. Christopher K. Mirabelli, Ph.D.
Director
Director
132.51K
+82.07%
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Winklevoss Capital Management, LLC
8.48%
Severns (Sean Michael)
6.14%
BlackRock Institutional Trust Company, N.A.
2.40%
Simplify Asset Management Inc
1.92%
Vanguard Capital Management, LLC
1.86%
Other
79.20%
Shareholders
Shareholders
Proportion
Winklevoss Capital Management, LLC
8.48%
Severns (Sean Michael)
6.14%
BlackRock Institutional Trust Company, N.A.
2.40%
Simplify Asset Management Inc
1.92%
Vanguard Capital Management, LLC
1.86%
Other
79.20%
Shareholder Types
Shareholders
Proportion
Family Office
8.48%
Individual Investor
8.02%
Investment Advisor
7.81%
Corporation
1.24%
Investment Advisor/Hedge Fund
0.81%
Venture Capital
0.69%
Research Firm
0.33%
Hedge Fund
0.18%
Other
72.42%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
114
11.73M
12.01%
-9.05M
2025Q4
110
8.00M
14.12%
-12.05M
2025Q3
109
9.06M
16.46%
-11.77M
2025Q2
120
18.70M
45.12%
-8.55M
2025Q1
140
18.85M
45.62%
-6.95M
2024Q4
134
21.35M
55.72%
-2.16M
2024Q3
140
20.83M
54.42%
+2.16M
2024Q2
141
20.87M
54.74%
+4.28M
2024Q1
149
9.36M
39.74%
-1.79M
2023Q4
154
7.72M
34.00%
-3.79M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Winklevoss Capital Management, LLC
8.28M
9.21%
+8.28M
--
Oct 24, 2025
Severns (Sean Michael)
6.00M
6.67%
+6.00M
--
Nov 12, 2025
BlackRock Institutional Trust Company, N.A.
2.34M
2.6%
+2.22M
+1770.24%
Dec 31, 2025
Simplify Asset Management Inc
1.87M
2.08%
+896.71K
+91.91%
Dec 31, 2025
Beigene Ltd
1.22M
1.35%
+1.22M
--
Oct 31, 2024
HealthCare Ventures LLC
676.32K
0.75%
-20.91K
-3.00%
Oct 24, 2025
Susquehanna International Group, LLP
557.18K
0.62%
+470.98K
+546.41%
Dec 31, 2025
Geode Capital Management, L.L.C.
530.19K
0.59%
+218.00K
+69.83%
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Simplify Health Care ETF
0.37%
iShares Micro-Cap ETF
0%
Dimensional US Core Equity 1 ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
0%
Avantis US Small Cap Equity ETF
0%
Simplify Health Care ETF
Proportion0.37%
iShares Micro-Cap ETF
Proportion0%
Dimensional US Core Equity 1 ETF
Proportion0%
DFA Dimensional US Sustainability Core 1 ETF
Proportion0%
Avantis US Small Cap Equity ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
Jun 20, 2023
Merger
10→1
Jun 20, 2023
Merger
10→1
Jun 20, 2023
Merger
10→1
Jun 20, 2023
Merger
10→1
Date
Ex-dividend Date
Type
Ratio
Jun 20, 2023
Merger
10→1
Jun 20, 2023
Merger
10→1
Jun 20, 2023
Merger
10→1
Jun 20, 2023
Merger
10→1
